| Dr Ronak Jani, MD | |
|
145 W 4th St, Suite 201, Cookeville, TN 38501-2447 | |
| (931) 783-2902 | |
| (931) 783-2219 |
| Full Name | Dr Ronak Jani |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 27 Years |
| Location | 145 W 4th St, Cookeville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417182304 | NPI | - | NPPES |
| 6023620 | Other | TN | BCBS |
| 7100423600 | Medicaid | TN | |
| Q008180 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 51102 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Lexington | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.
Texas would seek relief from federal Medicaid rules and nudge the needy into private health insurance with taxpayer subsidies under a bill the House tentatively approved Friday. The vote, mostly along party lines, was 97-45.
Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.
Acacia Pharma announces positive results from its Phase II study of APD421, in the prevention of post-operative nausea & vomiting (PONV).
A research team led by the National Neuroscience Institute has uncovered a novel function of the Amyloid Precursor Protein (APP), one of the main pathogenic culprits of Alzheimer's disease. This discovery may help researchers understand how the protein goes awry in the brains of Alzheimer's disease patients, and potentially paves the way for the development of innovative therapeutics to improve the brain function of dementia patients.
› Verified 2 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518360296 PECOS PAC ID: 5597867184 Enrollment ID: O20150206000249 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.
Texas would seek relief from federal Medicaid rules and nudge the needy into private health insurance with taxpayer subsidies under a bill the House tentatively approved Friday. The vote, mostly along party lines, was 97-45.
Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.
Acacia Pharma announces positive results from its Phase II study of APD421, in the prevention of post-operative nausea & vomiting (PONV).
A research team led by the National Neuroscience Institute has uncovered a novel function of the Amyloid Precursor Protein (APP), one of the main pathogenic culprits of Alzheimer's disease. This discovery may help researchers understand how the protein goes awry in the brains of Alzheimer's disease patients, and potentially paves the way for the development of innovative therapeutics to improve the brain function of dementia patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ronak Jani, MD 127 N Oak Ave, Suite D, Cookeville, TN 38501-2435 Ph: (931) 783-5857 | Dr Ronak Jani, MD 145 W 4th St, Suite 201, Cookeville, TN 38501-2447 Ph: (931) 783-2902 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced that new data for BMS747158, the company's novel drug candidate in clinical development as a Positron Emission Tomography (PET) perfusion imaging agent, will be featured in an oral presentation at the American College of Cardiology 59th Annual Scientific Session taking place March 14-16, 2010 in Atlanta.
Texas would seek relief from federal Medicaid rules and nudge the needy into private health insurance with taxpayer subsidies under a bill the House tentatively approved Friday. The vote, mostly along party lines, was 97-45.
Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.
Acacia Pharma announces positive results from its Phase II study of APD421, in the prevention of post-operative nausea & vomiting (PONV).
A research team led by the National Neuroscience Institute has uncovered a novel function of the Amyloid Precursor Protein (APP), one of the main pathogenic culprits of Alzheimer's disease. This discovery may help researchers understand how the protein goes awry in the brains of Alzheimer's disease patients, and potentially paves the way for the development of innovative therapeutics to improve the brain function of dementia patients.
› Verified 2 days ago
Dr. Stephen T Moore, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1101 Neal St, Suite 102, Cookeville, TN 38501 Phone: 931-526-1581 Fax: 931-526-5973 | |
Stephanie Marie Smith, FNP-BC Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 105 Cherry Ave, Cookeville, TN 38501 Phone: 931-528-5811 | |
Dalia Miller, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Blvd, Suite 103, Cookeville, TN 38501 Phone: 931-783-2902 Fax: 931-783-2219 | |
Supriya Kohli, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Blvd, Suite 103, Cookeville, TN 38501 Phone: 931-783-2770 Fax: 931-525-1176 | |
Donald R Atkinson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1200 S Willow Ave, Cookeville, TN 38506 Phone: 931-423-4123 Fax: 931-432-5838 | |
Viswa B. Durvasula, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 225 North Willow Avenue, Suite Number 1, Cookeville, TN 38501 Phone: 931-372-8700 |